ACCELERATE DIAGNOSTICS, INC.

(AXDX)
  Report
Delayed Nasdaq  -  04:00 2022-08-09 pm EDT
1.800 USD   +0.56%
07/25Accelerate Diagnostics scheduled call to review 2022 second quarter results
PR
07/11Accelerate Diagnostics' Accelerate Arc Module, BC Kit Get CE Marking
MT
07/11Accelerate Diagnostics announces commercialization in Europe of its Accelerate Arc™ system having completed IVDR registration
PR
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/03/2022 08/04/2022 08/05/2022 08/08/2022 08/09/2022 Date
1.8(c) 1.95(c) 2.13(c) 1.79(c) 1.8(c) Last
530 526 516 668 561 753 765 874 236 737 Volume
+8.43% +8.33% +9.23% -15.96% +0.56% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 12,9 M - -
Net income 2022 -73,4 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,73x
Yield 2022 -
Sales 2023 16,7 M - -
Net income 2023 -83,3 M - -
Net Debt 2023 - - -
P/E ratio 2023 -2,02x
Yield 2023 -
Capitalization 143 M 143 M -
Capi. / Sales 2022 11,1x
Capi. / Sales 2023 8,56x
Nbr of Employees 220
Free-Float 66,8%
More Financials
Company
Accelerate Diagnostics, Inc. is an in-vitro diagnostics company engaged in providing solutions that improve patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live... 
More about the company
Ratings of Accelerate Diagnostics, Inc.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
D
More Ratings
All news about ACCELERATE DIAGNOSTICS, INC.
07/25Accelerate Diagnostics scheduled call to review 2022 second quarter results
PR
07/11Accelerate Diagnostics' Accelerate Arc Module, BC Kit Get CE Marking
MT
07/11Accelerate Diagnostics announces commercialization in Europe of its Accelerate Arc&trad..
PR
06/30ACCELERATE DIAGNOSTICS, INC : Other Events (form 8-K)
AQ
06/24ACCELERATE DIAGNOSTICS, INC.(NASDAQC : AXDX) dropped from Russell 3000 Growth Index
CI
06/24ACCELERATE DIAGNOSTICS, INC.(NASDAQC : AXDX) dropped from Russell 3000E Growth Index
CI
06/24ACCELERATE DIAGNOSTICS, INC.(NASDAQC : AXDX) dropped from Russell 2000 Index
CI
06/24ACCELERATE DIAGNOSTICS, INC.(NASDAQC : AXDX) dropped from Russell 2000 Growth Index
CI
06/24ACCELERATE DIAGNOSTICS, INC.(NASDAQC : AXDX) dropped from Russell Small Cap Comp Growth In..
CI
06/24ACCELERATE DIAGNOSTICS, INC.(NASDAQC : AXDX) dropped from Russell 3000E Index
CI
06/24ACCELERATE DIAGNOSTICS, INC.(NASDAQC : AXDX) dropped from Russell 3000 Index
CI
06/24ACCELERATE DIAGNOSTICS, INC.(NASDAQC : AXDX) dropped from Russell Small Cap Completeness I..
CI
06/24ACCELERATE DIAGNOSTICS, INC.(NASDAQC : AXDX) dropped from Russell 2500 Growth Index
CI
06/24ACCELERATE DIAGNOSTICS, INC.(NASDAQC : AXDX) dropped from Russell 2000 Dynamic Index
CI
06/24ACCELERATE DIAGNOSTICS, INC.(NASDAQC : AXDX) dropped from Russell 2500 Index
CI
More news
News in other languages on ACCELERATE DIAGNOSTICS, INC.
07/11Le module Arc d'Accelerate Diagnostics, le kit BC obtiennent le marquage CE
05/16Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS annonce un chiffre d'affaires de 3 million..
05/16Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS annonce un chiffre d'affaires de 3 million..
05/16Accelerate Diagnostics, Inc. annonce ses résultats pour le premier trimestre clos le 31..
05/16Accelerate Diagnostics annonce la commercialisation de son système Accelerate Arc ayant..
More news
Analyst Recommendations on ACCELERATE DIAGNOSTICS, INC.
More recommendations
Chart ACCELERATE DIAGNOSTICS, INC.
Duration : Period :
Accelerate Diagnostics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ACCELERATE DIAGNOSTICS, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 1,80 $
Average target price 1,00 $
Spread / Average Target -44,4%
EPS Revisions
Managers and Directors
Jack Phillips President, Chief Executive Officer & Director
Steven Reichling Chief Financial & Accounting Officer
John Patience Chairman
Lawrence Mertz Senior VP & Head-Research & Development
Jack W. Schuler Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ACCELERATE DIAGNOSTICS, INC.-65.52%143
THERMO FISHER SCIENTIFIC-12.94%228 785
DANAHER CORPORATION-13.30%208 770
INTUITIVE SURGICAL, INC.-35.19%85 396
EDWARDS LIFESCIENCES CORPORATION-21.70%65 379
SIEMENS HEALTHINEERS AG-22.79%59 158